Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin in Intracranial Infection
NCT03585426Phase 4Unknown
- Sponsor
- Xijing Hospital
- Start
- Mar 2016
- Primary completion
- Dec 2018
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
Phase 4, randomised, open-label trial of vancomycin in intracranial infection (2 arms), sponsored by Xijing Hospital. Primary endpoint: Vancomycin concentration in serum and cerebrospinal fluid at 12 hours. Status: unknown.
02
Drugs
vancomycin
03
Conditions
intracranial infection
Beyond the preview
Go deeper on NCT03585426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03585426.